BioStem Technologies Company Description

BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.

It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.

The company is also engages in the repackaging and distribution of active pharmaceutical ingredients and other pharmaceutical compounding supplies; and develops and markets nutraceutical products under the Dr.

Dave’s Best and Nesvik Organics brands, as well as other non-proprietary products in the United States and internationally.

The company sells products through e-commerce platforms. BioStem Technologies, Inc. was incorporated in 2006 and is based in Pompano Beach, Florida.

BioStem Technologies, Inc.

Country	United States
Founded	2006
Industry	Biotechnology
Sector	Healthcare
Employees	33
CEO	Jason Matuszewski

Contact Details

Address: 2836 Center Port Circle Pompano Beach, Florida 33064 United States
Phone	954 380 8342
Website	biostemtechnologies.com

Stock Details

Ticker Symbol	BSEM
Exchange	OTCMKTS
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US0906842002
SIC Code	8731

Key Executives

Name	Position
Jason V. Matuszewski	Chief Executive Officer, President, Secretary and Chairman
Michael A. Fortunato CPA	Chief Financial Officer
Andrew Van Vurst CTBS	Chief Operating Officer and Director
Noah Agron	Vice President of Corporate Finance and Strategy
Morgan Kim	Vice President of Corporate and Legal Compliance
Barry J. Hassett	Senior Vice President of Marketing
Dr. David M. Woynarowski	Chief Medical Officer
Larry Jones	Chief Revenue Officer
Dr. Irmgard Huber M.D.	International Medical Advisor and Interim Chief Medical Officer
Shawn F. McCarrey	Chief Commercial Officer